About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

378040 studies
in
220 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 06/14/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 06/14/2021.

Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit

Clinicaltrials.gov identifier NCT03934112

Recruitment Status Not yet recruiting

First Posted May 1, 2019

Last update posted May 1, 2019

Study Description

Brief summary:

This study will allow correlating transfusion monitoring and patients' prognostic according to the chosen outcome criteria. These data could thus represent a basis for transfusion recommendations, except for intensive care and vital emergencies. It will also bring information about the actual transfusion monitoring in intensive care unit (ICU), in the period following the stay in the ICU and after hospital discharge.

  • Condition or Disease:Transfusion Related Complication
  • Intervention/Treatment:
  • Phase: N/A
Detailed Description

N/A

Study Design
  • Study Type: Observational
  • Estimated Enrollment: 150000 participants
  • Observational Model: Cohort
  • Time Perspective: Retrospective
  • Official Title: Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care
  • Estimated Study Start Date: June 2019
  • Estimated Primary Completion Date: December 2020
  • Estimated Study Completion Date: December 2020
Outcome Measures
  • Primary Outcome Measures: 1. Survival at 90 days after leaving ICU [ Time Frame: Day 90 ]
    All-cause mortality 90 days after leaving ICU
Eligibility Criteria
  • Ages Eligible for Study: (Child, Adult, Older Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: No
  • Sampling Method: Probability Sample
  • Study Population: All patients treated in medical and surgical resuscitation units of Besançon and Dijon university hospitals during the study period (from 01/01/2012 to 31/12/2017) are concerned.
Criteria

Inclusion criteria:

- Patient admitted to medical and surgical resuscitation units of Besançon and Dijon
university hospitals, all causes considered

- Patient admitted between 1st January 2012 to 31st December 2017

Contacts and Locations
Contacts

Contact: Maxime Desmarets, PhD 0033 381 218 359 maxime.desmarets@univ-fcomte.fr

Locations
Sponsors and Collaborators

Centre Hospitalier Universitaire de Besancon

More Information
  • Responsible Party: Centre Hospitalier Universitaire de Besancon
  • ClinicalTrials.gov Identifier: NCT03934112 History of Changes
  • Other Study ID Numbers: API/2016/72
  • First Posted: May 1, 2019 Key Record Dates
  • Last Update Posted: May 1, 2019
  • Last Verified: April 2019
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No